Seizure frequency in adults with Wolf-Hirschhorn syndrome
Jeanie C Worthington1, Alan S Rigby, Oliver W Quarrell
1Department of Clinical Genetics, Sheffield Children's Hospital, Sheffield, UK.
Abstract:
Epilepsy is a characteristic feature of Wolf-Hirschhorn syndrome (WHS) with onset usually in the first 2 years of life. There have been several reports of epilepsy ceasing as children get older. We have inspected a register of WHS cases from the UK and identified 27 adults with the condition; their mean age was 24.8 years (range 17-40 years). We conducted a telephone survey and asked parents to comment on their experience of seizures in WHS. In 18 patients (66%) a seizure had not occurred within 3 years. The mean age of those who have been seizure free for over 3 years was 23.7 years (range 17-33 years) whereas for those who had a recent seizure their mean age was 27.1 years (range 17-40 years). The mean age of the last seizure for those who were seizure free for 3 years was 11.3 years (range 2-28 years); in the majority of patients, seizures ceased within childhood years. Many parents commented that seizures were precipitated by fever. Individuals with WHS who had a deletion were more likely to be seizure free than those with a translocation. This reached statistical significance: chi(2) = 4.6, P = 0.03, odds ratio = 6.5 (95% CI 1.1-38.6). Data from this survey may be helpful when counseling families with a very young child with WHS.
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy ll: Types
Seizures ll: Types
Seizures l: Introduction
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

